金吾财讯 | 山东新华制药股份(00719)公布，近日，公司收到国家药品监督管理局核准签发葡萄糖酸钙注射液(10ml：1g)的《药品补充申请批准通知书》，该产品通过仿制药质量和疗效一致性评价，有利于进一步提升该产品的市场竞争力。 葡萄糖酸钙注射液临床用于治疗钙缺乏，急性血钙过低、碱中毒及甲状旁腺功能低下所致的手足搞弱症；过敏性疾患；镁中毒时的解救；氟中毒的解救；心脏复苏时应用(如高血钾或低血钙，或钙通道阻滞引起的心功能异常的解救)。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.